Targeted Therapies in Pediatric Oncology: Updates 2022 - Virtual Symposium


Program Overview


The symposium includes lectures on the latest and advanced therapies in pediatric solid tumors, leukemias, and lymphomas (immunotherapies, antibody-based therapies …etc.) to improve the outcomes of pediatric hematology-oncology patients. In addition to panel discussions on challenges of applying novel treatments in Leukemias, lymphomas, and solid tumors in resource-limited settings.


Target Audience


This activity is designed for physicians, scientists, and healthcare professionals involved in childhood cancer care and research.


This activity has been approved for AMA PRA Category 1 CreditTM.


This activity is organized by the AUBMC Continuing Medical Education (CME) Office.